Policy & Medicine

Congressional Budget Office Releases: Alternative Approaches to Reducing Prescription…

Thomas Sullivan Oct 10, 2024 0

As healthcare costs soar, the Congressional Budget Office (CBO) has recently shed light on a hot political issue: the perceived high cost of prescription drugs in the United States. Their latest report, published in October 2024, meticulously analyzes various policy measures aimed at curbing these costs. The Core Problem Prescription drug…

Policy and Medicine Compliance Update – November 2023…

Thomas Sullivan Dec 1, 2023 0

Policy and Medicine Compliance Update October 2023 Issue…

Thomas Sullivan Oct 20, 2023 0

Congressional Budget Office Releases: Alternative Approaches to…

As healthcare costs soar, the Congressional Budget Office (CBO) has recently shed light on a hot political issue: the perceived high cost of prescription drugs in the United States. Their latest…

Global Update on Transparency Reporting: Key Changes and…

In a recent global compliance presentation at the Informaconnect Transparency, Aggregate Spend and HCP Engagement, Elon Shelf, Senior Compliance Advisor at MedPro, shared updates on transparency…

SCOTUS Rejects Chevron Deference

On June 28, 2024, the Supreme Court rejected the doctrine of Chevron deference in the closely watched case of Loper Bright Enterprises v. Raimondo. In a 6-3 decision, the Court held that Chevron’s…

CMS Issues Enforcement Report on NSA and ACA

The United States Centers for Medicare and Medicaid Services (CMS) Center for Consumer Information and Insurance Oversight recently issued a report on health insurance market reforms, including the…

DOJ Announces False Claims Act Settlement with Hospice Care…

Intrepid USA, along with several whole-owned subsidiaries, recently reached a $3.85 million settlement with the United States Department of Justice (DOJ) to resolve allegations that the nationwide…

DOJ Announces $8.8 Million FCA and AKS Statute Settlement with…

The United States Department of Justice (DOJ) and National Interventional Radiology Partners (NIRP) recently announced an $8.8 million settlement that resolves allegations that the company violated…

OPDP Sends Untitled Letter to AbbVie Over Ubrelvy Television Ad

The United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) recently sent an Untitled Letter to AbbVie, Inc., regarding a television ad starring Serena Williams…

James Comer Calls on PBM Executives to Revise Testimony…

James Comer, Chairman of the United States House Committee on Oversight and Accountability, called on CEOs of three pharmacy benefit managers (PBMs) to correct the record for statements made during…

Rise of the Resistance: Challenging Carbapenem-Resistant…

In the ongoing battle against antibiotic-resistant infections, continuous education and adaptation of new strategies are crucial. This October, healthcare professionals specializing in infectious…

Oncology Unscripted with John Marshall: The Role of EMRs and…

In today's healthcare environment, physicians face numerous challenges that significantly impact their professional lives and personal well-being. Among these, the complexities of electronic medical…

Recent Study Finds Explosive Growth in 340B Program

Berkeley Research Group (BRG) recently published a study on the relative size of the 340B Program, by comparing it to other federal prescription drug programs and to the overall market for brand…

CMS’ ETC Model Had No Change on Home Dialysis or Kidney…

Recently, JAMA Health Forum published an investigation, “Pay-for-Performance Incentives for Home Dialysis Use and Kidney Transplant,” focused on the Centers for Medicare and Medicaid Services (CMS)…